Intracellular glutathione as a possible direct blocker of HIV type 1 reverse transcription

AIDS Research and Human Retroviruses

Volumn 12, Issue 17, 1996, Pages 1635-1638

  Kameoka, Masanori ^a   Okada, Yohei ^a   Tobiume, Minoru ^a   Kimura, Takuro ^a   Ikuta, Kazuyoshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE; RNA DIRECTED DNA POLYMERASE;

ARTICLE; CONTROLLED STUDY; GLUTATHIONE METABOLISM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MURINE LEUKEMIA VIRUS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

EID: 0030477198     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.1635     Document Type: Article

References (34)

1. Eck HP, Gmuender H, Hartmann M, Petzoldt D, Daniel V, and Droege W: Low concentrations of acid-soluble thiol (cysteine) in the blood plasma of HIV-1 infected patients. Biol Chem Hoppe Seyler 1989;370:101-108.
2. Borum P, Goldberg D, Lederman M, Skowron G, and Rowe W: Altered glutathione status of HIV positive patients. FASEB J 1992;6:5.
3. Staal FJT, Roederer M, Israelski DM, Bubp J, Mole LA, McShane D, Deresinski SC, Ross W, Sussman H, Paju PA, Anderson MT, Moore W, Ela SW, Herzenberg LA, and Herzenberg LA: Intracellular glutathione levels in T cell subset decrease in HIV-infected individuals. AIDS Res Hum Retroviruses 1992;8:305-311.
4. Barditch-Crovo P, Svobodova V, and Lietman P: Apparent deficiency of glutathione in the PBMCs of people with AIDS depends on method of expression. J Acquir Immune Defic Syndr 1995;8:313-318.
5. Meister A and Anderson ME: Glutathione. Annu Rev Biochem 1983;52:711-760.
6. Hamilos DL and Wedner HJ: The role of glutathione in lymphocyte activation. I. Comparison of inhibitory effects of buthionine sulfoximine and O-cyclohexene-1-one by nuclear size transformation. J Immunol 1985;135:2740-2747.
7. Suthanthiran M, Anderson ME, Sharma VK, and Meister A: Glutathione regulated activation-dependent DNA synthesis in highly purified normal human T lymphocytes stimulated via the CD2 and CD3 antigens. Proc Natl Acad Sci USA 1990;87:3343-3347.
8. Halliwell B and Cross CE: Reactive oxygen species, antioxidants, and acquired immunodeficiency syndrome. Sense or speculation? Arch Intern Med 1991;151:29-31.
9. Kimura T, Kameoka M, and Ikuta K: Amplification of superoxide anion generation in phagocytic cells by HIV-1 infection. FEBS Lett 1993;326;232-236.
10. Kameoka M, Kimura T, and Ikuta K: Superoxide enhances the spread of HIV-1 infection by cell-to-cell transmission. FEBS Lett 1993;331:182-186.
11. Schreck R, Rieber P, and Baeuerle PA: Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J 1991;10:2247-2258.
12. Staal FJT, Roederer M, Herzenberg LA, and Herzenberg LA: Intracellular thiols regulate activation of nuclear factor κB and transcription of human immunodeficiency virus. Proc Natl Acad Sci USA 1990;87:9943-9947.
13. Mihm S, Ennen J, Pessara U, Kurth R, and Droge W: Inhibiton of HIV-1 replication and NF-κB activity by cysteine and cysteine derivatives. AIDS 1991;5:497-503.
14. Roederer M, Staal F, Raju PA, Ela SW, Herzenberg LA, and Herzenberg LA: Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine. Proc Natl Acad Sci USA 1990;87:4884-4888.
15. Roederer M, Raju PA, Staal FJT, Herzenberg LA, and Herzenberg LA: N-Acetylcysteine inhibits latent HIV expression in chronically infected cells. AIDS Res Hum Retroviruses 1991;7:563-567.
16. Kalebic T, Kinter A, Poli G, Anderson ME, Meister A, and Fauci AS: Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetylcysteine. Proc Natl Acad Sci USA 1991;88:986-990.
17. Harakeh S and Jariwalla RJ: Comparative study of the anti-HIV activities of ascorbate and thiol-containing reducing agents in chronically HIV-infected cells. Am J Clin Nutr 1991:54 (Suppl. 6):1231S-1235S.
18. Ho W-Z and Douglas SD: Glutathione and N-acetylcysteine suppression of human immunodeficiency virus replication in human monocyte/macrophages in vitro. AIDS Res Hum Retroviruses 1992;8:1249-1253.
19. Lioy J, Ho W-Z, Cutilli JR, Polin RA, and Douglas SD: Thiol suppression of human immunodeficiency virus type 1 replication in primary cord blood monocyte-derived macrophages in vitro. J Clin Invest 1993;91:495-498.
20. Raju PA, Herzenberg LA, Herzenberg LA, and Roederer M: Glutathione precursor and antioxidant activities of N-acetylcysteine and oxothiazolidine carboxylate compared in in vitro studies of HIV replication. AIDS Res Hum Retroviruses 1994;10:961-967.
21. Nottet HSLM, van Asbeck BS, de Graaf L, de Vos NM, Visser MR, and Verhoef J: Role for oxygen radicals in self-sustained HIV-1 replication in monocyte-derived macrophages: Enhanced HIV-1 replication by N-acetyl-L-cysteine. J Leuk Biol 1994;56:702-707.
22. Staal FJ, Roederer M, Raju PA, Anderson MT, Ela SW, Herzenberg LA, and Herzenberg LA: Antioxidants inhibit stimulation of HIV transcription. AIDS Res Hum Retroviruses 1993;9:299-306.
23. Aillet F, Gougerot-Pocidalo M-A, Virelizier J-L, and Israel N: Appraisal of potential therapeutic index of antioxidants on the basis of their in vitro effects on HIV replication in monocytes and interleukin 2-induced lymphocyte proliferation. AIDS Res Hum Retroviruses 1994;10:405-411.
24. Verma IM: Studies on reverse transcriptase of RNA tumor viruses. III. Properties of purified Moloney murine leukemia virus DNA polymerase and associated RNase H. J Virol 1975;15:843-854.
25. Veronese FM, Copeland TD, DeVico AL, Rahman R, Oroszan S, Gallo RC, and Sarngadharan MG: Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV. Science 1986;231:1289-1291.
26. Minowada J, Ohnuma T, and Moore GE: Rosette forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes. J Natl Cancer Inst 1972;49:891-895.
27. Kameoka M, Kimura T, Okada Y, Nakaya T, Kishi M, and Ikuta K: High susceptibility of U937-derived subclones to infection with human immunodeficiency virus type 1 is correlated with virus-induced cell differentiation and superoxide generation. Immunopharmacology 1995;30:89-101.
28. Nakaya T, Fujinaga K, Kishi M, Oka S, Kurata T, Jones IM, and Ikuta K: Nonsense mutations in the vpr gene of HIV-1 during in vitro virus passage and in HIV-1 carrier-derived peripheral blood mononuclear cells. FEBS Lett 1994;354:17-22.
29. Pang S, Koyanagi Y, Miles S, Wiley C, Vinters HV, and Chen ISY: High levels of unintegrated HIV-1 DNA in brain tissue of AIDS dementia patients. Nature (London) 1990;343:85-89.
30. Shirazi Y and Pitha PM: Interferon α-mediated inhibition of human immunodeficiency virus type 1 provirus synthesis in T-cells. Virology 1993;193:303-312.
31. Verdin E: DNase 1-hypersensitive sites are associated with both long terminal repeats and with the intragenic enhancer of integrated human immunodeficiency virus type 1. J Virol 1991;65:6790-6799.
32. Kinter AL, Poli G, and Fauci AS: N-Acetyl-cysteine is a potent suppressor of human immunodeficiency virus transcription in persistently infected cells. Trans Assoc Am Phys CV 1992;105:36-43.
33. Pani A, Marongiu ME, and la Cola P: Modulatory effect of N-acetyl-L-cysteine on the HIV-1 multiplication in chronically and acutely infected cell lines. Antivir Res 1993;22:31-43.
34. Eylar E, Rivera-Quinones C, Molina C, Bacz I, Molina F, and Mercado CM: N-Acetylcysteine enhances T cell functions and T cell growth in culture: Int Immunol 1993;5:97-101.